Neurosense Therapeutics Ltd
NASDAQ:NRSN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurosense Therapeutics Ltd
NASDAQ:NRSN
|
IL |
|
J
|
JPMorgan Chase & Co
DUS:CMC
|
US |
|
Industria de Diseno Textil SA
OTC:IDEXF
|
ES |
|
Resmed Inc
OTC:RSMDF
|
US |
|
N
|
NEC Corp
XHAM:NEC1
|
JP |
|
Samsung Electronics Co Ltd
F:SSUN
|
KR |
|
Roche Holding AG
LSE:0TDF
|
CH |
|
I
|
Intuit Inc
F:ITU
|
US |
|
U
|
Unilever PLC
XMUN:UNV0
|
UK |
|
Promotica SpA
MIL:PMT
|
IT |
|
H
|
HSBC Holdings PLC
F:HBC1
|
UK |
|
A
|
Amgen Inc
XHAM:AMG
|
US |
|
M
|
Mondelez International Inc
SGO:MDLZ
|
US |
|
Dollarama Inc
TSX:DOL
|
CA |
|
Christian Dior SE
PAR:CDI
|
FR |
|
C
|
CXApp Inc
NASDAQ:CXAI
|
US |
|
E
|
Endeavour Silver Corp
SWB:EJD
|
CA |
Shareholder Yield
Current shareholder yield for NRSN is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NRSN Price
Neurosense Therapeutics Ltd
| Average Annual Return | -20.1% |
| Standard Deviation of Annual Returns | 43.01% |
| Max Drawdown | -93% |
| Market Capitalization | 31m USD |
| Shares Outstanding | 35 350 000 |
| Percentage of Shares Shorted | 2.4% |
